Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Operating Leases (2019 - 2025)

Aspen Aerogels (ASPN) has disclosed Operating Leases for 7 consecutive years, with $20.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases fell 12.62% year-over-year to $20.7 million, compared with a TTM value of $20.7 million through Sep 2025, down 12.62%, and an annual FY2024 reading of $23.1 million, up 5.67% over the prior year.
  • Operating Leases was $20.7 million for Q3 2025 at Aspen Aerogels, down from $21.5 million in the prior quarter.
  • Across five years, Operating Leases topped out at $23.7 million in Q3 2024 and bottomed at $4.1 million in Q1 2021.
  • Average Operating Leases over 5 years is $17.7 million, with a median of $20.7 million recorded in 2025.
  • The sharpest move saw Operating Leases surged 261.16% in 2021, then fell 12.62% in 2025.
  • Year by year, Operating Leases stood at $13.0 million in 2021, then grew by 3.58% to $13.5 million in 2022, then skyrocketed by 62.8% to $21.9 million in 2023, then grew by 5.67% to $23.1 million in 2024, then fell by 10.38% to $20.7 million in 2025.
  • Business Quant data shows Operating Leases for ASPN at $20.7 million in Q3 2025, $21.5 million in Q2 2025, and $22.3 million in Q1 2025.